Subcutaneous sumatriptan auto-injector is a selective 5-HT1B/1D receptor agonist that causes vasoconstriction of cranial blood vessels and inhibits neuropeptide release in the trigeminovascular system. When used for cluster headache, it rapidly reduces pain by targeting serotonin receptors and interrupting the neurogenic inflammatory cascade associated with severe headache symptoms.